DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Famitinib is an investigational drug.
There have been 31 clinical trials for Famitinib. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2020.
The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Breast Neoplasms. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd., Fudan University, and Sun Yat-sen University.
There are forty-two US patents protecting this investigational drug and three hundred and ninety-eight international patents.
Recent Clinical Trials for Famitinib
|Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer||Jiangsu HengRui Medicine Co., Ltd.||Phase 3|
|A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer||Jiangsu HengRui Medicine Co., Ltd.||Phase 2|
|Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma||Jiangsu HengRui Medicine Co., Ltd.||Phase 2|
Top disease conditions for Famitinib
Top clinical trial sponsors for Famitinib
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Famitinib||Try Before You Buy||TYK2 inhibitors and uses thereof||Nimbus Lakshimi, Inc. (Cambridge, MA)||Try Before You Buy|
|Famitinib||Try Before You Buy||Substituted urea derivatives and pharmaceutical uses thereof||SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN)||Try Before You Buy|
|Famitinib||Try Before You Buy||Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis||Genentech, Inc. (South San Francisco, CA)||Try Before You Buy|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Famitinib||European Patent Office||EP3344624||2035-09-02||Try Before You Buy|
|Famitinib||Hong Kong||HK1256997||2035-09-02||Try Before You Buy|
|Famitinib||Japan||JP2018532706||2035-09-02||Try Before You Buy|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|